Ipramidil

This classification denotes a vasodilating agent with the molecular formula C10H16N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9ZPC9768EH, chemically known as n,n-diisopropyl-3,4-furazandicarboxamide 2-oxide but generally known as ipramidil, which bears US NIH Compound Identifier 71268. European Medicines Agency schedules Ipramidil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08275MIG. The term IPRAMIDIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). IPRAMIDIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ipramidil under HS 29349990 and SITC 51579. As of Q4 2014, IPRAMIDIL remains the US FDA Preferred Term for this commodity. Ipramidil bears US NLM identifiers UMLS ID C0654557 and NCI Concept Code C74326. SMILES: CC(C)NC(=O)C1=NO[N+](=C1C(=O)NC(C)C)[O-].